Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
fertility
Biotech
Ferring terminates fertility trials after ‘portfolio assessment’
Two trials testing the pairing of choriogonadotropin beta with Rekovelle have been terminated as part of “a broader portfolio assessment.”
Darren Incorvaia
Apr 2, 2026 2:00pm
NAYA spins off cancer drug business 6 months after INVO merger
Apr 15, 2025 8:05am
FDA clears its first at-home, OTC artificial insemination kit
Dec 7, 2023 12:28pm
Take 2: CooperSurgical pays $300M for Cook Medical assets
Nov 3, 2023 10:28am
Women's health biotech to move lead compound into IVF patients
Jun 27, 2023 9:45am
Fairtility welcomes EU approval for embryo assessment AI
Jul 5, 2022 3:32pm
